Tag Archives: Inc. (U.S.)

Pressemitteilungen

Global Poultry Disease Diagnostics Market Valued Over US$ 326.2 Bn in 2017 and Projected to Expand at CAGR of 10.2% over 2017 to 2025

Precision Business Insights (PBI) in its report titled “Global Poultry Disease Diagnostics: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 and Forecast 2018-2025” assesses the market performance over eight years forecast period over 2018-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

Market Boosts and Restraining Factors:
Global poultry disease diagnostics market is anticipated to offer lucrative business opportunities over the forecast period. Surge in disease prevalence of diseases and availability of advanced technologies coupled with increased R&D expected to focus on novel diagnostic kits in order diagnosis of various poultry diseases.

Poultry industry has been experiencing tremendous changes from the decade, in order meet the burgeoning demand for meat and eggs. As per FAO, poultry sector has been expanding at 5 percent per annum meat production is growing at 30% rate.

Lower production cost, increased demand, specialized and more integrated facilities, and improvements in animal genetics, optimized nutrition, and adoption of state-of-art technologies are expected to create demand for poultry disease diagnostic market.

Rapid evolution of pandemic diseases is expected to create demand for poultry disease diagnostics market. Favorable government policies and availability of financial support are witnessing to stimulate the market over the forecast timeline. However, inadequate reimbursement policies are expected to acts as bottleneck for poultry disease diagnostics market.

 

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-poultry-disease-diagnostics-market/#ulp-h4n2eZVGqb32xpPc

 

Region Overview: Poultry Disease Diagnostics Market:
Geographically market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Poultry disease diagnostics market is expected to gain traction over the forecast time frame owing to surge in the poultry production across the globe. As per statistics, Brazil produced 11.4 million tonnes, which is accounted for 12.7% of total global chicken production in 2011. Rising production of poultry coupled with increased chronic diseases witness unlock the potential of poultry disease diagnostics market.

China poultry disease diagnostics market is expected to dominate the market share in future. It is accounted for 13% of global poultry production. Surge in demand for white meat is expected to create demand for poultry disease diagnostics market.

Spain poultry disease diagnostics market is expected to witness for robust growth rate due to increased production as well as spreading of poultry diseases.

 

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-poultry-disease-diagnostics-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Segmentation: Poultry Disease Diagnostics Market
Poultry Disease Diagnostics market has been segmented on the basis of product, and disease type.

Based on the Product, poultry disease diagnostics market has been segmented into the following:

  • PCR test kits
  • ELISA test kits
  • Others

Based on disease, poultry disease diagnostics market has been segmented into the following:

1. Bacterial diseases

  • Fowl Typhoid/ Pullorum disease
  • Nectrotic enteritis
  • Fowl cholera
  • Avian Tuberculosis
  • Botulinum

2. Viral diseases

  • Newcastle disease
  • Adenovirus group
  • Infectious bursal disease
  • Reovirus infections

3. Parasitic diseases

  • Coccidiosis
  • Lymphoid Leukosis

4. Mycoses and Mycotoxicoses

  • Aspergillosis
  • Aspergillus granulomatous dermatitis
  • Aflatoxicosis
  • Candidiasis

5. Neoplastic diseases

  • Virus-induced neoplastic diseases marek’s disease
  • Lymphoid leukosis
  • Myelocytomatosis
  • Erythroblastosis

6. Others

 

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/global-poultry-disease-diagnostics-market/#ulp-c654SbFYO64MsOhu

 

Market overview: Poultry Disease Diagnostics Market
Spreading various bacterial, virus diseases, increased R&D expenditure, availability of advanced diagnostic test kits, and adoption of novel technologies enables create demand for poultry disease diagnostics market in future.

Region Overview: Poultry Disease Diagnostics Market
Geographically market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Poultry disease diagnostics market is expected to gain traction over the forecast time frame owing to surge in the poultry production across the globe. As per statistics, Brazil produced 11.4 million tons, which is accounted for 12.7% of total global chicken production in 2011. Rising production of poultry coupled with increased chronic diseases witness unlock the potential of poultry disease diagnostics market.

China poultry disease diagnostics market is expected to dominate the market share in future. It is accounted for 13% of global poultry production. Surge in demand for white meat is expected to create demand for poultry disease diagnostics market.

Spain poultry disease diagnostics market is expected to witness for robust growth rate due to increased production as well as spreading of poultry diseases.

Market Participants: Poultry Disease Diagnostics Market
Global Poultry Disease Diagnostics market is dominated by players such as IDEXX Laboratories, Inc., BioChek, Thermo Fisher Scientific Inc., QIAGEN N.V., Zoetis, Inc., GD Animal Health, Boehringer Ingelheim, IDvet, AgroBioTek Internacional, AffiniTech, LTD., BioNote, Inc., BioinGentech Biotechnologies, Inc., and MEGACOR Diagnostik GmbH.

Key Market Developments: Poultry Disease Diagnostics Market

  • The report provides granular level information about the market size, regional market share and forecast from 2018-2025
  • The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

 

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-poultry-disease-diagnostics-market/

 

About Precision Business Insights:

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact us:
Kemp House,
152 – 160 City Road,
London EC1V 2NX

Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553

Aktuelle Nachrichten Finanzen/Wirtschaft Gesundheit/Medizin Internationales Marketing/Werbung Pressemitteilungen

Global Thrombocytopenia Treatment Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Thrombocytopenia Treatment Market: By Drug Class (Lysosomal Enzyme, Platelet Stimulating Agents, and Glucocorticoids), By Disease Indication (Leukemia, Hemolytic Uremic Syndrome, Immune Thrombocytopenia, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global thrombocytopenia treatment market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Thrombocytopenia Treatment Market

Thrombocytopenia is the condition where in which the patient has a low platelet count. The root cause for the thrombocytopenia are the platelet splenic sequestration, inefficiency in the production of the platelets and the destruction of the platelets. Thrombocytopenia is either inherited or acquired. It usually occurs owing to various disorders such as leukemia and immune system related conditions. This is commonly found in both adults and children. In thrombocytopenia condition show very less symptoms and is mild. In some cases, the count of the platelets is so low that it causes dangerous internal bleeding, as the patient affected with the thrombocytopenia leads to delayed blood clotting or sometimes no blood clotting.

 

Market Dynamics: Thrombocytopenia Treatment Market

Increase in the prevalence of thrombocytopenia all across the globe and rising count of the chronic hepatitis C cases, which causes the risk of thrombocytopenia are likely to drive the growth of the market. The growing government support by financial aids to the patients in developing and under developed countries expected to drive the market revenue growth over forecast period. However, the stringent government regulations for approvals of newer treatments and increasing introduction of the generic drugs may hinder the growth of the market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/thrombocytopenia-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Thrombocytopenia Treatment Market

Thrombocytopenia treatment market is segmented based on the drug class, disease indication, and distribution channel

 

Based on the drug class, the market is segmented into the following:

  • Lysosomal Enzyme
  • Platelet Stimulating Agent
  • Glucocorticoids

Based on the disease indication, the market is segmented into the following:

  • Leukemia
  • Hemolytic Uremic Syndrome
  • Immune Thrombocytopenia
  • Others

Based on the distribution channel, the market is segmented into the following:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/thrombocytopenia-treatment-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Thrombocytopenia Treatment Market

Geographically, global thrombocytopenia treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America thrombocytopenia treatment market is growing due to increase in the prevalence of thrombocytopenia. The deep-rooted healthcare infrastructure is also anticipated to drive the growth of the market in the region. The awareness among the patient population regarding the new treatment methods is likely to enhance the growth of the market in the region. The adoption of the new treatment procedures by the patient pool is boosting the growth of the thrombocytopenia treatment market in the region.

 

Competition Assessment: Thrombocytopenia Treatment Market

Some of the players in the global thrombocytopenia treatment market include:

  • Merck & Co., Inc. (U.S)
  • Bristol-Myers Squibb Company (U.S)
  • ViroMed Co., Ltd (South Korea)
  • Rigel Pharmaceuticals, Inc. (U.S)
  • Shionogi & Co., Ltd. (Japan)
  • Cellerant Therapeutics, Inc. (U.S)

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/thrombocytopenia-treatment-market/#ulp-14mlyhjMGhVjZqa3

 

Notable Market Developments: Thrombocytopenia Treatment Market

  • In February 2018, Shionogi & Co., Ltd announced that the New Drug Application (NDA) for lusutrombopag (S-888711), an investigational, once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist, has been accepted for filing and has been granted Priority Review by the U.S. Food & Drug Administration (FDA)

 

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/thrombocytopenia-treatment-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

Aktuelle Nachrichten Finanzen/Wirtschaft Gesundheit/Medizin Internationales Marketing/Werbung

Global Uveal Melanoma Therapeutics Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Uveal Melanoma Therapeutics Market: By Disease Type (Choroidal Melanomas, Iris Melanomas, and Ciliary Body Melanomas), By Treatment Type (Chemotherapy, Immunotherapy, and Targeted Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global uveal melanoma therapeutics market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Uveal Melanoma Therapeutics Market

Uveal melanoma is a disease in which malignant (cancer) cells form in the tissues of the eye. The tumors arise from the melanocytes that reside within the uvea giving color to the eye. Uveal melanoma begins between the three layers of the wall of the eye. The first layer (outer layer) includes sclera and the cornea at the front of the eye. The inner layer has a retina, that senses light and send images. The middle layer is the layer in which the melanoma forms. This layer is called as uvea.

Increase in the prevalence of uveal melanoma is driving the growth of the market. The rising awareness among the people regarding the disease among healthcare fraternity is anticipated to drive the growth of the uveal melanoma therapeutics market. However, the higher cost of the therapy and reimbursement policies are may constrain the growth of the market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/uveal-melanoma-therapeutics-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Uveal Melanoma Therapeutics Market

Uveal melanoma therapeutics market is segmented based on the disease type, treatment type, and distribution channel.

Based on the disease type, the market is segmented into the following:

  • Choroidal Melanomas
    • Small Melanomas
    • Medium-sized Melanomas
    • Large Melanomas
  • Iris melanomas
  • Ciliary Body Melanomas

Based on the treatment type, the market is segmented into the following:

  • Chemotherapy
    • Methotrexate
    • Others
  • Immunotherapy Drugs
    • Pembrolizumab
    • Ipilimumab
    • Others
  • Targeted Drugs

Based on the distribution channel, the market is segmented into the following:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/uveal-melanoma-therapeutics-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Uveal Melanoma Therapeutics Market

Geographically, global uveal melanoma therapeutics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America uveal melanoma therapeutics market is driven by increase in the prevalence of the eye related disorders. The growing patient population with uveal melanoma disorder expected fuel the market growth in the region. According to the American Cancer Society, about nine of 10 melanomas of the eye develop in the choroid. It also states that 2,730 new cases were detected in 2014 of uveal melanoma in the U.S.

 

Competition Assessment: Uveal Melanoma Therapeutics Market

Some of the players in the global uveal melanoma therapeutics market include:

  • Eli Lilly & Co. (U.S)
  • Novartis AG (Switzerland)
  • AstraZeneca plc (UK)
  • Pfizer, Inc. (U.S)
  • Merck (U.S)
  • Roche (Switzerland)
  • Amgen (U.S)
  • Bayer (Germany)
  • Spectrum Pharmaceuticals, Inc. (U.S)

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/uveal-melanoma-therapeutics-market/#ulp-14mlyhjMGhVjZqa3

 

Notable Market Developments: Uveal Melanoma Therapeutics Market

  • Bristol-Myers Squibb and National Cancer Institute (NCI) completed the phase II study of Nivolumab in combination with Ipilimumab for Uveal Melanoma

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/uveal-melanoma-therapeutics-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

Aktuelle Nachrichten Gesundheit/Medizin Internationales Marketing/Werbung Pressemitteilungen

Global Vitrectomy Machines Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Vitrectomy Machines Market: By Product Type (Vitrectomy Machines, Vitrectomy Packs, Microscopic Illumination Equipment, Surgical Instruments, and Others), By Application (Retinal Detachment, Diabetic Retinopathy, Trauma, Macular Surgery, Pediatric Retinal Disorders, and Others), By End Users (Hospitals, Eye Clinics, and Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global vitrectomy machines was valued at US $ XX Mn in 2017 and is expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Vitrectomy Machines Market

The vitrectomy is a surgical procedure that is carried out by the specialist where the vitreous humor is located in order to provide a better access to the retina. This booklet describes various types of repairs such as the treatment of macular holes, removal of scar tissue, and repair of retinal detachments. In order to help retina hold in position after surgery, gas bubble or silicon oil, saline are injected.

 

Market Dynamics: Vitrectomy Machines Market

Increase in the prevalence of eye diseases in the geriatric population are majorly driving the growth of the vitrectomy machines market. The advancements in the technology is thus playing a significant role in the growth of the market. The growing awareness among the patient population is the adoption of new surgical procedures. However, the high cost of the surgical process, the lack of government support to the non-profitable organizations and poor healthcare policies in developing countries may be hindered by the growth of the vitrectomy machines market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/vitrectomy-machines-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Vitrectomy Machines Market

Vitrectomy machines market is segmented based on product type, applications, and end user.

Based on the product type, the market is segmented into the following:

  • Vitrectomy Machines
  • Vitrectomy Packs
  • Microscopic Illumination Equipment
  • Surgical Instruments
  • Others

Based on the applications, the market is segmented into the following:

  • Retinal detachment
  • Diabetic retinopathy
  • trauma
  • Macular Surgery
  • Pediatric Retinal Disorders
  • Others

Based on the end user, the market is segmented into the following:

  • Hospitals
  • Eye Clinics
  • Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/vitrectomy-machines-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis: Vitrectomy Machines Market

Geographically, Global Vitrectomy Machinery is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America vitrectomy machines market driven by increase in the prevalence of eye diseases. Fraternity in the region is driving the market. Followed by North America is the European and Asia Pacific regions are dominating the market.

 

Competition Assessment: Vitrectomy Machines Market

Some of the players in the global vitrectomy machine market include:

  • IRIDEX Corporation (US)
  • Synergetics, Inc. (US)
  • Bausch & Lomb (US)
  • Optos PLC (UK)
  • Topcon Corporation (Japan)
  • Leica Microsystems GmbH (Germany)
  • Carl Zeiss Meditec AG (Germany)
  • Alcon, Inc. (US)

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/vitrectomy-machines-market/#ulp-14mlyhjMGhVjZqa3

 

Notable Market Developments: Vitrectomy Machines Market

  • In August 2017, Bausch + Lomb has launched the Stellaris Elite vision enhancement system for retinal surgery in the US

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/vitrectomy-machines-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firms, which follows a holistic approach to solve the needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and making better decisions. We provide consulting, syndicated and customized market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): 1-866-598-1553

Website @ https://www.precisionbusinessinsights.co m

Aktuelle Nachrichten Gesundheit/Medizin Internationales Marketing/Werbung Mode/Lifestyle

Global Wearable Insulin Devices Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Wearable Insulin Devices Market: By Product Type (Patches and Pods), By Age Group (Adults and Pediatrics), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global wearable insulin devices market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Wearable Insulin Devices Market

Wearable insulin devices are the medical devices that helps in controlling or maintaining the blood glucose in the patient’s body. The insulin is the major part in the treatment of diabetes. Insulin is the hormone made by the pancreas which allows the body to use or store the sugar or the glucose from carbohydrates form the food. It allows to maintain the blood sugar level form either getting too high, which would result in hyperglycemia or from getting too low which would result in hypoglycemia.

 

Market Dynamics: Wearable Insulin Devices Market

Increase in the prevalence of diabetes is the major factor anticipated to drive the growth of wearable insulin devices market. Increasing health issues such as obesity and launch technologically advanced devices anticipated to fuel the growth of wearable insulin devices market. The rising awareness among the patient population with regard to advanced treatment options and increasing healthcare expenditure are expected to boost the wearable insulin devices market. The adoption of the self-care diabetes management methods and increasing R&D activities are providing opportunity to the manufacturers to further expansion of the market. However, the high cost of the device may hamper the growth of the wearable insulin devices market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/wearable-insulin-devices-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Wearable Insulin Devices Market

Wearable insulin devices market is segmented based on the product type, age group, and distribution channel

Based on the product type, the market is segmented into the following:

  • Patches
  • Pods

Based on the age group, the market is segmented into the following:

  • Adults
  • Pediatrics

Based on the distribution channel, the market is segmented into the following:

  • Hospital Pharmacies
  • Online Pharmacies
  • Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/wearable-insulin-devices-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Wearable Insulin Devices Market

Geographically, global wearable insulin devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America wearable insulin devices market is dominant when compared with that of the other regional markets owing to favorable reimbursement policies and increase in the prevalence of diabetes and obesity. According to the Centers for Disease Control and Prevention (CDC) in the year of 2016, there were 29 million patients in U.S. who are still suffering with diabetes, of which 21.0 million patients were diagnosed and 8.1 million patients are undiagnosed. The increasing awareness about the self-treatment procedures is also enhancing the growth of the wearable insulin devices market. The Asia Pacific is the region expected to offer lucrative growth opportunities owing to large untapped market and availability of large diabetic patient pool in India and China.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/wearable-insulin-devices-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Wearable Insulin Devices Market

Some of the players in the global wearable insulin devices market include:

  • Omnipod (U.S)
  • Valeritas, Inc. (U.S)
  • CeQur (Switzerland)
  • Prometheon Pharma (U.S)
  • Sproutel (U.S)
  • MedicSen (Spain)

 

Notable Market Developments: Wearable Insulin Devices Market

  • In January 2018, Valeritas launches V-Go wearable insulin delivery device in Puerto Rico.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/wearable-insulin-devices-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

Aktuelle Nachrichten Auto/Verkehr Computer/Internet/IT Energie/Natur/Umwelt Essen/Trinken Finanzen/Wirtschaft Gesellschaft/Politik Gesundheit/Medizin Pressemitteilungen Reisen/Tourismus

Global Wearable Insulin Devices Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Wearable Insulin Devices Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Wearable Insulin Devices Market: By Product Type (Patches and Pods), By Age Group (Adults and Pediatrics), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global wearable insulin devices market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Wearable Insulin Devices Market

Wearable insulin devices are the medical devices that helps in controlling or maintaining the blood glucose in the patient’s body. The insulin is the major part in the treatment of diabetes. Insulin is the hormone made by the pancreas which allows the body to use or store the sugar or the glucose from carbohydrates form the food. It allows to maintain the blood sugar level form either getting too high, which would result in hyperglycemia or from getting too low which would result in hypoglycemia.

 

Market Dynamics: Wearable Insulin Devices Market

Increase in the prevalence of diabetes is the major factor anticipated to drive the growth of wearable insulin devices market. Increasing health issues such as obesity and launch technologically advanced devices anticipated to fuel the growth of wearable insulin devices market. The rising awareness among the patient population with regard to advanced treatment options and increasing healthcare expenditure are expected to boost the wearable insulin devices market. The adoption of the self-care diabetes management methods and increasing R&D activities are providing opportunity to the manufacturers to further expansion of the market. However, the high cost of the device may hamper the growth of the wearable insulin devices market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/wearable-insulin-devices-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Wearable Insulin Devices Market

Wearable insulin devices market is segmented based on the product type, age group, and distribution channel

Based on the product type, the market is segmented into the following:

  • Patches
  • Pods

Based on the age group, the market is segmented into the following:

  • Adults
  • Pediatrics

Based on the distribution channel, the market is segmented into the following:

  • Hospital Pharmacies
  • Online Pharmacies
  • Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/wearable-insulin-devices-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Wearable Insulin Devices Market

Geographically, global wearable insulin devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America wearable insulin devices market is dominant when compared with that of the other regional markets owing to favorable reimbursement policies and increase in the prevalence of diabetes and obesity. According to the Centers for Disease Control and Prevention (CDC) in the year of 2016, there were 29 million patients in U.S. who are still suffering with diabetes, of which 21.0 million patients were diagnosed and 8.1 million patients are undiagnosed. The increasing awareness about the self-treatment procedures is also enhancing the growth of the wearable insulin devices market. The Asia Pacific is the region expected to offer lucrative growth opportunities owing to large untapped market and availability of large diabetic patient pool in India and China.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/wearable-insulin-devices-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Wearable Insulin Devices Market

Some of the players in the global wearable insulin devices market include:

  • Omnipod (U.S)
  • Valeritas, Inc. (U.S)
  • CeQur (Switzerland)
  • Prometheon Pharma (U.S)
  • Sproutel (U.S)
  • MedicSen (Spain)

 

Notable Market Developments: Wearable Insulin Devices Market

  • In January 2018, Valeritas launches V-Go wearable insulin delivery device in Puerto Rico.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/wearable-insulin-devices-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

 

 

 

Aktuelle Nachrichten Auto/Verkehr Computer/Internet/IT Energie/Natur/Umwelt Essen/Trinken Finanzen/Wirtschaft Gesellschaft/Politik Gesundheit/Medizin Pressemitteilungen Reisen/Tourismus

Global Vitrectomy Machines Market – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Vitrectomy Machines Market – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Vitrectomy Machines Market: By Product Type (Vitrectomy Machines, Vitrectomy Packs, Microscopic Illumination Equipment, Surgical Instruments, and Others), By Application (Retinal Detachment, Diabetic Retinopathy, Trauma, Macular Surgery, Pediatric Retinal Disorders, and Others), By End User (Hospitals, Eye Clinics, and Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global vitrectomy machines market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Vitrectomy Machines Market

Vitrectomy is a surgical procedure that is undertaken by the specialist where the vitreous humor gel that fills the eye cavity is removed in order to provide a better access to the retina. This allows various types of repairs such as treatment of macular holes, removal of scar tissue, and laser repair of retinal detachments. In order to help retina hold in position after the surgery, gas bubble or silicon oil, saline are injected.

 

Market Dynamics: Vitrectomy Machines Market

Increase in the prevalence of eyes diseases and rise in the geriatric population are majorly driving the growth of the vitrectomy machines market. The advancements in the technology is also playing a significant role in the growth of the market. The growing awareness among the patient population is enabling to adopt the new surgical procedures which is enhancing the vitrectomy machines market. However, the high cost of the surgical process, lack of government support to the non-profitable organizations and poor healthcare policies in developing countries may hinder the growth of the vitrectomy machines market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/vitrectomy-machines-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Vitrectomy Machines Market

Vitrectomy machines market is segmented based on the product type, applications, and end user.

Based on the product type, the market is segmented into the following:

  • Vitrectomy Machines
  • Vitrectomy Packs
  • Microscopic Illumination Equipment
  • Surgical Instruments
  • Others

Based on the applications, the market is segmented into the following:

  • Retinal Detachment
  • Diabetic Retinopathy
  • Trauma
  • Macular Surgery
  • Pediatric Retinal Disorders
  • Others

Based on the end user, the market is segmented into the following:

  • Hospitals
  • Eye Clinics
  • Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/vitrectomy-machines-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Vitrectomy Machines Market

Geographically, global vitrectomy machines market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America vitrectomy machines market growth driven by increase in the prevalence of eye diseases. Cost-effectiveness of surgical procedures and the awareness about the surgical procedures among healthcare fraternity in the region is driving the market. Followed by North America is the European and Asia Pacific regions are dominating the market.

 

Competition Assessment: Vitrectomy Machines Market

Some of the players in the global vitrectomy machines market include:

  • IRIDEX Corporation (U.S)
  • Synergetics, Inc. (U.S)
  • Bausch & Lomb (U.S)
  • Optos PLC (UK)
  • Topcon Corporation (Japan)
  • Leica Microsystems GmbH (Germany)
  • Carl Zeiss Meditec AG (Germany)
  • Alcon, Inc. (U.S)

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/vitrectomy-machines-market/#ulp-14mlyhjMGhVjZqa3

 

Notable Market Developments: Vitrectomy Machines Market

  • In August 2017, Bausch + Lomb has launched the Stellaris Elite vision enhancement system for retinal surgery in the US

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/vitrectomy-machines-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

 

 

 

Aktuelle Nachrichten Auto/Verkehr Computer/Internet/IT Energie/Natur/Umwelt Essen/Trinken Finanzen/Wirtschaft Gesellschaft/Politik Gesundheit/Medizin Pressemitteilungen Reisen/Tourismus

Global IT Spending on Clinical Analytics Market – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

 

Global IT Spending on Clinical Analytics Market: By Solution (In-House and Outsource), By Platform (Stand-Alone and Integrated), By Deployment (Cloud-Based and On-Premise), By End User (Payer and Provider), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global IT spending on clinical analytics market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

Market Outline: IT Spending on Clinical Analytics Market

Clinical analytics encompasses the capture and use of discrete clinical data to identify and measure quality, patient safety, or service line efficiencies and improvements. Clinical analytics and business intelligence tools have emerged as a top priority for the hospital IT leaders who are moving towards accountable care adoption.

 

Market Dynamics: IT Spending on Clinical Analytics Market

Increase in the demand of value-based care for population health is driving the growth of the IT spending on clinical analytics market. Growing adoption of digital data management tools in the healthcare sector and digitization is playing a vital role in the healthcare which is enhancing the growth of the IT spending on clinical analytics market. The ability of the clinical analytical tools in providing highly refined data in the lesser span of time is anticipated to drive the growth of the IT spending on clinical analytics market. However, the difficulties faced in the analysis of the healthcare owing to its huge volume and data lack of skilled professionals is hampering the growth of the IT spending on clinical analytics market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/it-spending-on-clinical-analytics-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: IT Spending on Clinical Analytics Market

IT spending on clinical analytics market is segmented based on the solution, platform, deployment and end-user

Based on the solution, the market is segmented into the following:

  • In-House
    • Hardware
    • Software
    • Services
  • Outsource

Based on the platform, the market is segmented into the following:

  • Stand-Alone
  • Integrated

Based on the deployment, the market is segmented into the following:

  • Cloud-Based
  • On-Premise

Based on the end user, the market is segmented into the following:

  • Payer
    • Insurance Companies
    • Government
    • Other
  • Provider
    • Hospitals
    • Clinics

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/it-spending-on-clinical-analytics-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  IT Spending on Clinical Analytics Market

Geographically, global IT spending on clinical analytics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America IT spending on clinical analytics market driven by rising demand for the quality care in the healthcare sector. The support from the government in developing the healthcare sector is anticipated to fuel the IT spending on clinical analytics market in the region. Europe IT spending on clinical analytics market falls next to North America. The Asia Pacific IT spending on clinical analytics market is expected to grow at significant rate over the forecast period.

Competition Assessment: IT Spending on Clinical Analytics Market

Some of the players in the global IT spending on clinical analytics market include:

  • CareCloud Corporation (U.S)
  • Medical Information Technology, Inc. (U.S)
  • Hewlett-Packard Enterprise Development LP (U.S)
  • ArborMetrix, Inc. (U.S)
  • McKesson Corporation (U.S)
  • Cerner Corporation (U.S)
  • IBM Corporation (U.S)
  • Optum, Inc. (U.S)
  • Allscripts Healthcare Solutions, Inc. (U.S)

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/it-spending-on-clinical-analytics-market/#ulp-14mlyhjMGhVjZqa3

 

Notable Market Developments: IT Spending on Clinical Analytics Market

  • In January 2018, Allscripts has acquired Practice Fusion business in order to expand its big data insights and analytics, data sharing technologies, and clinical trial solutions to enable life sciences organizations to accelerate bringing life-changing therapies to market.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/it-spending-on-clinical-analytics-market/

 

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

 

 

 

 

Aktuelle Nachrichten Auto/Verkehr Computer/Internet/IT Energie/Natur/Umwelt Essen/Trinken Finanzen/Wirtschaft Gesundheit/Medizin Pressemitteilungen Reisen/Tourismus

Global Induced Pluripotent Stem Cells Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Induced Pluripotent Stem Cells Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Induced Pluripotent Stem Cells Market: By Technology (Cell Production, Cell Acquisition, Expansion and Sub-Culture, Cryopreservation, and Cryopreservation), By End User (Academic Institutions, Research Institutes, Biotechnology Companies, and Others), and Geography -Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global induced pluripotent stem cells market was valued at US $ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

Market Outline: Induced Pluripotent Stem Cells Market
Induced pluripotent stem cells are one of the types of the pluripotent stem cells which can be generated from the adult cells. The induced pluripotent stem cells are generally derived from the blood cells or the skin cells that have been reprogrammed back into an embryonic-like pluripotent state. It enables to develop an unlimited source of any type of human cells that are needed for therapeutic purposes. As they are generated from the adult stem cells, they doesn’t require embryo. The Induced pluripotent stem cells play a vital role in the regenerative medicine.

Free sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/induced-pluripotent-stem-cells-market/#ulp-4H8Z4LpNMLEuOnnx

Market Dynamics: Induced Pluripotent Stem Cells Market
Increase in the prevalence of various chronic diseases such as leukemia, diabetes, and heart diseases is majorly driving the growth of the induced pluripotent stem cells market. The growing adoption of regenerative medicine is likely to drive the growth of the market. The potential of early stage of human cells development is helping in the customization of flawless match of genes which is enhancing the growth of the induced pluripotent stem cells market. However, the factors such as incomplete programming, premature cell death and higher cost involved in the treatment procedures are likely to hamper the growth of the induced pluripotent stem cells market.

Free TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/induced-pluripotent-stem-cells-market/#ulp-c654SbFYO64MsOhu

Market Scope: Induced Pluripotent Stem Cells Market
Induced pluripotent stem cells market is segmented based on the technology, and end user
Based on the technology, the market is segmented into the following:
• Cell Production
• Cell Acquisition
• Expansion and Sub-Culture
• Cryopreservation
Based on the end user, the market is segmented into the following:
• Academic Institutions
• Research Institutes
• Biotechnology Companies
• Others

Regional Analysis: Induced Pluripotent Stem Cells Market
Geographically, global induced pluripotent stem cells market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America induced pluripotent stem cells market growth driven by increase in the prevalence of chronic diseases such as cancer, heart diseases. The growing adoption of the new treatment procedures are likely to enhance the growth of the induced pluripotent stem cells market in the region. The Asia Pacific region is expected to show significant growth over the forecast period.

Ask Analyst for Full Information about this report @
https://www.precisionbusinessinsights.com/market-reports/induced-pluripotent-stem-cells-market/#ulp-14mlyhjMGhVjZqa3

Competition Assessment: Induced Pluripotent Stem Cells Market
Some of the players in the global induced pluripotent stem cells market include:
• Acelity Holdings, Inc. (U.S)
• StemCells, Inc. (U.S)
• Japan Tissue Engineering Co., Ltd. (Japan)
• Organogenesis Inc (U.S)
• Fujifilm Holding Corporation (Japan)
• Fate Therapeutics (U.S)
• Bristol-Myers Squibb Company (U.S)

Notable Market Developments: Induced Pluripotent Stem Cells Market
 In March 2015, FUJIFILM Holdings Corporation acquired Cellular Dynamics International, Inc.

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/induced-pluripotent-stem-cells-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

Aktuelle Nachrichten Auto/Verkehr Computer/Internet/IT Energie/Natur/Umwelt Essen/Trinken Finanzen/Wirtschaft Gesellschaft/Politik Gesundheit/Medizin Pressemitteilungen Reisen/Tourismus

Graft Versus Host Disease Treatment Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

 

Global Graft Versus Host Disease Treatment Market: By Product Type (Monoclonal Antibodies, Tyrosine Kinase Inhibitors, Thalidomide, and mTOR Inhibitors), By Disease Type (Acute Graft vs. Host Disease (aGvHD), Chronic Graft vs. Host Disease (cGvHD)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Geography – Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global graft versus host disease treatment market was valued at US $ XX Mn and expected to grow at 5.5% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Graft Versus Host Disease Treatment Market

Graft versus host disease is an immune-mediated disease. It is the medical complication in which there would be a complex interaction between the donor and the adaptive immunity of the recipient. The disease occurs when the bone marrow or the stem cells are transplanted. The treatment using the stem cells and bone marrow are used in the reconstruction of the damaged cells which surround the cancer cells. It is also used in the during solid organ transplantation. The chances of developing graft versus host disease is more in the allogeneic transplantation.

 

Market Dynamics: Graft Versus Host Disease Treatment Market

Rising count of the allogeneic hematopoietic stem cell transplant and increase in the prevalence of cancer patients are majorly driving the growth of graft versus host disease treatment market. The increasing bone marrow transplantations for various types of cancers is likely to drive the growth of the market. The growing R&D activities is helping in fastening up the drug development process which is expected to add fuel for the growth of the market. However, the higher investment in the initial stages of the clinical trials is likely to hamper the growth of the market. The strict government regulations for approvals is also hindering the growth of the graft versus host disease treatment market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/graft-versus-host-disease-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Graft Versus Host Disease Treatment Market

Graft versus host disease treatment market is segmented based on the product type, disease type, and distribution channel

Based on the product type, the market is segmented into the following:

  • Monoclonal Antibodies
  • Tyrosine Kinase Inhibitors
  • Thalidomide
  • mTOR Inhibitors
  • Others

Based on the disease type, the market is segmented into the following:

  • Acute Graft vs. Host Disease (aGvHD)
  • Chronic Graft vs. Host disease (cGvHD)

Based on the distribution channel, the market is segmented into the following:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/graft-versus-host-disease-treatment-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Graft Versus Host Disease Treatment Market

Geographically, global graft versus host disease treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America graft versus host disease treatment market growing due to increase in the prevalence of cancer. The rising count of the bone transplantations is also considerably high in this region. The increasing healthcare expenditure and adoption of the modern treatment options are adding scope for the growth of the market in this region.

 

Competition Assessment: Graft Versus Host Disease Treatment Market

Some of the players in the global graft versus host disease treatment market include:

  • Novartis AG (Switzerland)
  • Merck & Co. (U.S)
  • Soligenix, Inc. (U.S)
  • Mesoblast Ltd (Australia)
  • Sanofi (France)
  • Neovii Biotech GmbH (Switzerland)
  • Astellas Pharma Inc. (Japan)
  • Mallinckrodt Pharmaceuticals (UK)

 

Ask Analyst about this report @

https://www.precisionbusinessinsights.com/market-reports/graft-versus-host-disease-treatment-market/#ulp-14mlyhjMGhVjZqa3

 

Notable Market Developments: Graft Versus Host Disease Treatment Market

  • In November 2017, Merck & Co., Inc. received FDA Approval of PREVYMIS (letermovir) for Prevention of Cytomegalovirus (CMV) Infection and Disease in Adult Allogeneic Stem Cell Transplant Patients

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/graft-versus-host-disease-treatment-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com